News
-
Newsletter
Cancer treatments using inhibitors of CDK, a cell cycle regulator
Carna Newsletter Vol.16
-
Newsletter
ALK drug resistant mutations: Challenges for the treatment of lung cancer
Carna Newsletter Vol.15
-
Offers
2023 Year-End Campaign
We’ve got good news for you: a special discount for human Kinases from Carna Biosciences.
-
Technical Note
DGKα and DGKζ are key targets for cancer immunotherapy
Carna Newsletter Vol.14
-
Newsletter
The potential of PIKfyve inhibitor as a treatment of amyotrophic lateral sclerosis (ALS)
Carna Newsletter Vol.13
-
Offers
New Cellular CDK Assay Panel Launched and Special Offers from Carna
We are pleased to launch a new CDK (cyclin-dependent kinases) Cell-based Assay Panel for kinase researchers who are focusing on the CDK family.
…